Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes.

De Matteis, Eleonora; Sacco, Simona; Ornello, Raffaele

De Matteis, Eleonora; Sacco, Simona; Ornello, Raffaele.

Afiliación

De Matteis E; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, L'Aquila, Italy.
Sacco S; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, L'Aquila, Italy.
Ornello R; Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology, University of L'Aquila, L'Aquila, Italy.

Ther Clin Risk Manag ; 18: 359-378, 2022.

Article en En | MEDLINE | ID: mdl-35411146

Palabras clave

RCTs; erenumab; migraine; randomized clinical trials; real-world

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Ther Clin Risk Manag Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google